COMMUNIQUÉS West-GlobeNewswire

Tenaya Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
11/03/2026
Reported Promising Data for TN-201 and TN-401 Gene Therapies in Fourth Quarter of 2025; Additional Data Readouts and Pursuit of Regulatory Alignment for Each Program Planned in 2026 New Research Supports TN-301’s [...]
Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2025 Financial Results
11/03/2026
PLN-101095 Phase 1 data showed deep and durable ongoing responses in checkpoint inhibitor refractory solid tumors PLN-101095 accelerated development plan underway with initiation of Phase 1b indication expansion trial [...]
LogicMark, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 25, 2026
11/03/2026
LOUISVILLE, Ky., March 11, 2026 (GLOBE NEWSWIRE) -- LogicMark, Inc. (OTC: LGMK), a provider of emergency response systems, health communications devices, and technology for the growing personal safety and care economy, [...]
BioStem Technologies to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 24, 2026
11/03/2026
Conference call and webcast to be held at 4:30 PM ET POMPANO BEACH, Fla., March 11, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, [...]
Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook
11/03/2026
FHD-909 (LY4050784) Phase 1 dose-escalation advancing as planned, targeting SMARCA4 (BRG1)-mutant cancers with a focus on non-small cell lung cancer (NSCLC) Selective CBP degrader program with potential in ER+ breast [...]
Dyadic to Report 2025 Full Year Financial Results and Host Conference Call on Wednesday, March 25, 2026
11/03/2026
JUPITER, Fla., March 11, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. d/b/a Dyadic Applied BioSolutions ("Dyadic", "we", "us", "our", or the "Company") (Nasdaq: DYAI), a global biotechnology company focused on [...]
RadNet, Inc. to Present at the 28th Annual Barclays Global Healthcare Conference on Thursday, March 12th
11/03/2026
LOS ANGELES, March 11, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT ), a national leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, today announced that [...]
Alpha Pro Tech, Ltd. Announces Fourth Quarter and Full Year 2025 Financial Results
11/03/2026
Full Year 2025 Sales Increased to $59.1 Million, Up 2.3%, Compared to $57.8 Million for the Full Year of 2024 Net sales for the year ended December 31, 2025, were $59.1 million, up 2.3% compared to $57.8 million for the [...]
BioXcel Therapeutics Announces Closing of $8.0 Million Registered Direct Offering
11/03/2026
NEW HAVEN, Conn., March 11, 2026 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company built on artificial intelligence to develop transformative medicines in [...]
Pacira BioSciences Reaffirms Commitment to Shareholder Value Creation
11/03/2026
-- Issues Statement in Response to DOMA’s Nomination of Director Candidates -- -- No Shareholder Action Required at This Time -- BRISBANE, Calif., March 11, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: [...]
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
11/03/2026
ZUG, Switzerland, March 11, 2026 (GLOBE NEWSWIRE) -- The attached notifications relate to annual equity incentive awards granted to members of the executive committee of the Company. Attachments notification-of-managers [...]
Nyxoah Participera à la 36ème Conférence Annuelle Oppenheimer Healthcare MedTech & Services
11/03/2026
Nyxoah Participera à la 36ème Conférence Annuelle Oppenheimer Healthcare MedTech & Services Mont-Saint-Guibert, Belgique – 11 mars 2026, 22h05 CET / 16h05 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (« Nyxoah » [...]
Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
11/03/2026
Nyxoah to Participate in the Oppenheimer 36 th Annual Healthcare MedTech & Services Conference Mont-Saint-Guibert, Belgium – March 11, 2026, 10:05 pm CET / 4:05 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“ [...]
GUERBET : 2025 full-year results.
11/03/2026
2025 full-year results Revenue : €786.4 million, down 3.5% at CER 1 and like-for-like 2 , mainly due to the fall in activity in France Profitability : restated EBITDA margin 3 of 12.0% (at the high end of the adjusted [...]
GUERBET : Résultats annuels 2025.
11/03/2026
Résultats annuels 2025 Chiffre d’affaires : 786,4 M€, soit un repli de 3,5% à TCC 1 et périmètre comparable 2 , dû essentiellement à la baisse de l’activité en France Rentabilité : la marge d’EBITDA retraité 3 ressort à [...]
GUERBET : Change in Guerbet’s Board of Directors.
11/03/2026
Change in Guerbet’s Board of Directors Villepinte, March 11th, 2026: Guerbet (FR0000032526 GBT), a global leader in contrast agents and solutions for medical imaging, today announced, at its Board of Directors’ meeting [...]
GUERBET : Evolution du Conseil d’Administration de Guerbet.
11/03/2026
Evolution du Conseil d’Administration de Guerbet Villepinte, le 11 mars 2026 : Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l’imagerie médicale, annonce la nomination ce [...]
Solid Biosciences Provides Interim Positive Clinical Update on Phase 1/2 INSPIRE DUCHENNE Trial
11/03/2026
- 40 participants have been dosed with SGT-003 in the INSPIRE DUCHENNE trial to date - - Robust microdystrophin expression with consistent mechanistic evidence of dystrophin associated protein complex (DAPC) restoration [...]
Cosmos Health Purchases $600,000 of Bitcoin, Expands Digital Asset Holdings to $3,100,000
11/03/2026
CHICAGO, March 11, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced the purchase of $600,000 of [...]

Pages